Consortium of Multiple Sclerosis Centers (CMSC) Best Practices Guideline on the Use of Neurofilament Biomarkers in MS Erratum: This [...]
This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in [...]
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous [...]
This guideline was developed by a group of multiple sclerosis (MS) specialists, convened by the Consortium of Multiple Sclerosis Centers [...]
NARCOMS, the CMSC Patient Registry, is led by a team of world-renowned MS clinicians and researchers. Date from NARCOMS has provided the [...]
According to a new AAN guideline, Complementary and Alternative Medicine in Multiple Sclerosis, there is little evidence for the [...]
